15
Views
0
CrossRef citations to date
0
Altmetric
NSH Vendor Poster Award Winner

Analysis of HER2 Peptide - Based Analyte Control Slides

Pages 153-156 | Published online: 18 Jul 2013

References

  • Holden E, Luther E, Manoukian R, Henriksen M: A Novel Approach to Automated Quantitative Analysis of HER2 Expres-sion. Cambridge, MA: CompuCyte Corporation. Available at: http://www.compucyte.com/CompuCyte_Materials/Selected%20Presentations/Tissue/A%20Novel%20Approach%20to%20Automated%20Quantitative%20Analysis%20of%2OHER2%20Expression.pdf. Accessed November 20,2010.
  • Sompuram SR, Vani K, Messana E, Bogen SA: A molecular model of fonmalin fixation. Am J Clin Pathol 121:190–199,2004.
  • Sompuram SR, Vani K, Hafer LJ, Bogen SA: Antibodies immunoreactive with formalin-fixed tissue antigens recognize linear protein epitopes. Am J Clin Pathol 125:82–90,2006.
  • Sompuram SR, Vani K, Bogen SA: A molecular model of antigen retrieval using a peptide array. Am J Clin Pathol 125: 91–98,2006.
  • Sompuram SR, Kodela V, Zhang K, Ramanathan H, Radcliffe G, Falb P, et al.: A novel quality control slide for quantita-tive immunohistochemistry testing. J Histochem Cytochem 50:1425–1433,2002.
  • Bogen SA, Vani K, McGraw B, Federico V, Habib I, Zeheb R, et al.: Experimental validation of peptide immunohistochemis-try controls. Appl Immunohistochem Mol Morphol, 2008.
  • Shi SR, Liu C, Taylor CR: Standardization of immunohis-tochemistry for formalin-fixed, paraffin-embedded tissue sections based on the antigen-retrieval technique: From exper-iments to hypothesis. J Histochem Cytochem 55:105–109, 2007.
  • Burry RW: Specificity controls for immunocytochemical methods. J Histochem Cytochem 48:163–165,2000.
  • Wolff AC, Hammond MEH, Schwartz JN, Hagerty KU, Allred DC, Cote RJ, et al.: American Society of Clinical Oncology/ College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131:18–43,2007.
  • Vani K, Sompuram SR, Fitzgibbons P, Bogen SA: National HER2 proficiency test results using standardized quantitative controls. Arch Pathol Lab Med 132:211–216,2008.
  • Goldstein N, Hewitt SM, Taylor CR, Yaziji H, Hicks D: Members of ad-hoc committee on immunohistochemistry standardization: Recommendations for improved standardiza-tion of immunohistochemistry. Appl Immunohistochem Mol Morphol 15:124–133,2007.
  • Taylor CR, Levenson RM: Quantification of immunohis-tochemistry—issues concerning methods, utility and semi quantitative assessment II. Histopathol 49:411–424,2006.
  • Fitzgibbons PL, Murphy DA, Dorfman DM, Roche PC, Tubbs RR, Immunohistochemistry Committee, College of American Pathologists: Interlaboratory comparison of immunohistochem-ical testing for HER2: Results of the 2004 and 2005 College of American Pathologists HER2 Immunohistochemistry Tissue Microarray Survey. Arch Pathol Lab Med 130:1440–1445, 2006.
  • Swanson PE: SS102 Evidence-based immunohistochemistry: Technical validation of predictive and prognostic markers, 2008-09-25. Available at: http://www.clinchem.org/cgi/content/fill/48/3/410.
  • von Wasielewski R: Proficiency testing of immunohistochemi-cal biomarker assays in breast cancer. Virchows Arch 453:537–543,2008.
  • Sompuram SR, Kodela V., Ramanathan H, Wescott C, Radcliffe G, Bogen SA: Synthetic peptides identified from phage-displayed combinatorial libraries as immunodiagnostic assay surrogate quality-control targets. Clin Chem 48:410–420, 2002.
  • Bilous M, Dowsett M, Hanna W, Isola J, Lebeau A, Moreno A, et al.: Current perspectives on HER2 testing: A review of national testing guidelines. Mod Pathol 16:173–182,2003.
  • Mengel M, Hebel K, Kreipe H, von Wasielewski R: Standardized on-slide control for quality assurance in the immunohistochemical assessment of therapeutic target mole-cules in breast cancer. Breast J 11:34–40, 2005.
  • Bogen SA, Vani K, Sompuram SR: Molecular mechanisms of antigen retrieval: Antigen retrieval reverses steric interfer-ence caused by formalin-induced cross-links. Biotechnic & Histochem 22:1–9,2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.